An asthmatic patient with corticosteroid treatment for 45 years presented with slowly progressive limb muscle atrophy. His muscle symptoms were involved in four limbs and tongue, and deep tendon reflexes were exaggerated. Biopsied muscle pathology indicated the presence of neurogenic muscular atrophy in combination with corticosteroid myopathy. Furthermore, 8-hydroxy-deoxyguanosine (8-OH-dG) was prominently increased in mitochondrial and nuclear DNA. An aerobic exercise test demonstrated remarkable serum lactate elevation, which was attenuated by the administration of coenzyme Qio.
Introduction
Corticosteroid myopathy is a well-known side effect of long-term corticosteroid administration. Although the cause is not precisely known, it appears that the major action of corticosteroid is to induce muscle protein catabolism. This effect is prominent in type 2B (fast-twich) fibers, resulting in the fiber atrophy (1) . It has been generally accepted that corticosteroid does not interfere with the neuronal system. However, there are a few reports discordant with such a notion; fibrillation motor unit potentials (1) and delayed nerve conduction velocities (2) are observed under corticosteroid treatment. Following the large-dose corticosteroid treatment in status asthmatics, acute muscle symptomsoften occur involving asymmetric paresis of varying degrees of one or more limbs, occasionally with tetraplegia (3) (4) (5) . Because manypatients developed these symptomsafter receiving mechanical ventilation, several contributory factors other than corticosteroid itself have also been considered, such as muscle relaxants or consequent immobilization (3) (4) (5) . However, because somepatients develop these symptomswithout mechanical ventilation (4, 5) , corticosteroid-induced muscular damage should be considered at least in those patients. Although EMGusually reveals myopathic changes, some of them exhibit neurogenic muscular atrophies called asthmatic amyotrophy (5 
High-performance liquid chromatography with electrochemical detection (HPLC-EC)
After isolating mitochondria and nuclei from muscle samples (10), each DNAwas isolated and enzymatically hydrolyzed. 8-OH-dG and deoxy-guanosine (dG) were assayed by HPLC-EC, as reported elsewhere (7-9).
Mitochondrial enzymatic assays
Individual respiratory chain complexes (I-IV) were assayed in mitochondrial fractions of biopsied skeletal muscles, as reported elsewhere (8-10 
The PCR was performed according to the previous reports with minor modifications (1 1). Each PCRproduct was subcloned and sequenced. A positive control sample was obtained from a patient with chronic progressive external ophthalmoplegia (CPEO; 9).
Results

Histologic and electron microscopic findings
The muscle specimens revealed small group atrophy, angulated fibers ( Fig. 2A) , and lobulated fibers (Fig. 2B , asterisks). Myosin ATPase staining revealed that the atrophic fibers were preferentially type 2B fibers (Fig. 2C, arrows) . Glycogen was accumulated in subsarcolemmal regions of lobulated fibers, and in some of these atrophic fibers (Fig.  2D, arrows) . Ragged-red fibers were not observed in modified Gomori-Trichrome staining. The lobulated fibers, found in type 1 fibers, had many proliferative mitochondria on electron microscopy ( Fig. 2E ), but these mitochondria showedpreserved structures.
Aerobic exercise on bicycle ergometer
The aerobic exercise test demonstrated abnormal serum lactate elevation (Fig. 3) associated with a marked increase in 8-OH-dG in skeletal muscles from patients with chronic corticosteroid administration as well as mitochondrial encephalomyopathies (7-9).
The molar ratios of 8-OH-dG/dG in mitochondrial DNAand nuclear DNAwere prominently elevated tol4.2% and 7.6%, respectively, since we previously reported that the ratios in normal subjects were 0.211±0.071 (mean±SD) % and 0.121+ 0.068% in mitochondrial DNAand nuclear DNA,respectively (8).
Mitochondrial enzymatic analysis
The enzymatic activities of respiratory chain were as These mitochondrial changes are reminiscent of mitochondrial encephalomyopathies, however, the mitochondrial changes are not specific to mitochondrial encephalomyopathies but are observed in skeletal muscles of other neuromuscular disorders and even normal aging (14). In the case of skeletal muscle under corticosteroid treatment, reduced mitochondrial functions and morphological alterations such as enlargement, aggregation, and ragged-red fibers have been reported (15-17).
Recently, we reported that chronic corticosteroid administration significantly induced mitochondrial dysfunction associated with oxidative damage in skeletal muscle (8). The molar ratio of 8-OH-dG/dG was prominently increased in corticosteroid-treated skeletal muscles and this increase was similar to that observed in skeletal muscles of patients with mitochondrial diseases (7). Furthermore, we found two patients with long-term corticosteroid therapy, who exhibited oculoskeletal symptoms similar to those in a mitochondrial disease, chronic progressive external ophthalmoplegia (9). These findings suggest that long-term corticosteroid administration potentially induces oxidative stress-mediated mitochondrial damage in skeletal muscles as observed in mitochondrial diseases.
In patients with mitochondrial diseases, oxidative damage seems to be closely related to mitochondrial dysfunction and it plays an important role in the development of muscular damage (7) . Recently, we reported that mitochondrial diseases harbor unique apoptosis-related changes with overproduction of reactive oxygen species (18). It is well known that mitochondrial abnormalities exist not only in skeletal muscle but also in various organs including the nervous system, eye, heart, and endocrine system; these are called mitochondrial cytopathies. Particularly, neurogenic muscle atrophy and peripheral neuropathy are often observed and seem to result from mitochondrial dysfunction in the corresponding motor neurons (19, 20 
